bibliographic resource 4723821 [br/4723821]
https://w3id.org/oc/corpus/br/4723821

is a
title
  • Mutations within the EGFR signaling pathway: Influence on efficacy in FIRE-3—A randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild-type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC) patients.
publication date
  • 2014-01-01
contributor
format
identifier
part of